Research Article
OLFML2A Overexpression Predicts an Unfavorable Prognosis in Patients with AML
Table 3
Univariate and multivariate Cox regression analysis of factors associated with OS in TCGA-AML.
| Characteristics | Total (N) | HR (95% CI) univariate analysis | value univariate analysis | HR (95% CI) multivariate analysis | value multivariate analysis |
| Gender | 140 | | | | | Female | 63 | Reference | | | | Male | 77 | 1.030 (0.674–1.572) | 0.892 | | | Race | 138 | | | | | Asian and Black or African American | 11 | Reference | | | | White | 127 | 1.200 (0.485–2.966) | 0.693 | | | Age | 140 | | | | | ≤60 | 79 | Reference | | | | >60 | 61 | 3.333 (2.164–5.134) | <0.001 | 2.859 (1.819–4.494) | <0.001 | WBC count (×109/L) | 139 | | | | | ≤20 | 75 | Reference | | | | >20 | 64 | 1.161 (0.760–1.772) | 0.490 | | | BM blasts (%) | 140 | | | | | ≤20 | 59 | Reference | | | | >20 | 81 | 1.165 (0.758–1.790) | 0.486 | | | PB blasts (%) | 140 | | | | | ≤70 | 66 | Reference | | | | >70 | 74 | 1.230 (0.806–1.878) | 0.338 | | | Cytogenetic risk | 138 | | | | | Favorable | 31 | Reference | | | | Intermediate | 76 | 2.957 (1.498–5.836) | 0.002 | 2.031 (1.003–4.113) | 0.049 | Poor | 31 | 4.157 (1.944–8.893) | <0.001 | 2.506 (1.134–5.535) | 0.023 | FAB classifications | 139 | | | | | M0 | 14 | Reference | | | | M1&M2&M3&M4&M5&M6&M7 | 125 | 1.033 (0.517–2.062) | 0.927 | | | OLFML2A | 140 | | | | | Low | 71 | Reference | | | | High | 69 | 2.362 (1.534–3.639) | <0.001 | 2.198 (1.409–3.429) | <0.001 |
|
|